Skip to main content

Prexige FDA Approval Status

FDA Approved: No
Brand name: Prexige
Generic name: lumiracoxib
Company: Novartis AG
Treatment for: Osteoarthritis

Prexige (lumiracoxib) is a COX-2 inhibitor under review for the once-daily treatment of patients suffering from osteoarthritic pain. Although Prexige is currently approved in more than 50 countries, it is unlikely the painkiller will gain FDA approval.

Development timeline for Prexige

Sep 27, 2007Prexige Receives "Not Approvable" Letter in the US Despite Being One of the Most Studied COX-2 Inhibitors

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.